Conventional wisdom says a bigger government hand in health care means more scrutiny of outlays to highly profitable pharmaceuticals, insurers, and medical device makers. Indeed, with the Supreme Court voting 5-4 to uphold the Affordable Care Act, these sectors are all down today, amid a broad market pullback.
Continued here:
A Sick Rally, So to Speak, for Hospital Stocks – ( http://www …
Tags: act, address, care, conventional, court, device, makers, medical, pharmaceuticals, quick draw syringe, scrutiny